Study Title
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer (COMPPARE)
Purpose
To determine if prostate cancer patients treated with proton therapy, as compared to IMRT, experience:
Improved quality of life
Reduced toxicity
Non-inferior or even superior cancer control
To determine if Hypofractionated proton therapy is non-inferior to standard fractionated proton therapy in patient-reported outcomes & physician-reported toxicity.
Eligibility
Study Process
Trial Details
Investigator:
IRB:
University of Florida
IRB Number:
Trial Type:
NA
Sponsor:
Patient Centered Outcomes University of Florida
Contact Information:
Radiation Oncology Services